Aptamers in Focus: An Emerging Tool for Molecular Targeting

In this episode, we explore the growing role of aptamers, short, single-stranded oligonucleotides that bind to specific targets with high affinity and specificity. Often considered alternatives to antibodies, aptamers offer several advantages in terms of stability, cost, and synthesis. We examine the SELEX process used for aptamer selection, discuss current and potential applications in diagnostics and therapeutics, and highlight recent advancements in aptamer-based technologies. Whether you're in R&D, product development, or biotech strategy, this conversation provides practical insight into a rapidly evolving field.